medical condition treated by semaglutide Could GLP-1 Weight Loss Drugs Also Treat or Prevent Chronic Diseases? Semaglutide dose may matter more

In the long term, these drugs could help reduce the prevalence of obesity-related conditions, decreasing the burden on healthcare systems and improving the quality of life for millions globally

The MHRA has issued warnings about unlicensed weight loss products found to contain undeclared pharmaceutical substances, including sibutramine (a withdrawn appetite suppressant) and stimulant laxatives

GIP is a second incretin hormone

Semaglutide reduces circulating inflammatory markers like CRP, TNF-alpha, and IL-6 in studies of people with type 2 diabetes

The relationship between muscle mass and muscle strength in the elderly

Rapid weight loss itself can also contribute to fatigue as the body adapts to metabolic changes